Sample size re‐estimation – journey for a decade
2001; Wiley; Volume: 20; Issue: 4 Linguagem: Francês
10.1002/sim.532
ISSN1097-0258
Autores Tópico(s)Statistical Methods and Inference
ResumoStatistics in MedicineVolume 20, Issue 4 p. 515-518 Commentary Sample size re-estimation – journey for a decade Weichung Joseph Shih, Corresponding Author Weichung Joseph Shih Division of Biometrics, University of Medicine and Dentistry of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, U.S.A.Division of Biometrics, University of Medicine and Dentistry of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, U.S.A.Search for more papers by this author Weichung Joseph Shih, Corresponding Author Weichung Joseph Shih Division of Biometrics, University of Medicine and Dentistry of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, U.S.A.Division of Biometrics, University of Medicine and Dentistry of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, U.S.A.Search for more papers by this author First published: 05 February 2001 https://doi.org/10.1002/sim.532Citations: 67AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Shih WJ, Gould AL. Interim analysis for sample size reestimation without unblinding treatment group identification in double-blind clinical trials. Abstract no. 27, Society for Clinical Trials Eleventh Annual Meeting, Toronto, Ontario, Canada, 6–9 May 1990. Google Scholar 2 Stein C. A two-sample test fore a linear hypothesis whose power is independent of the variance. Annals of Mathematical Statistics 1945; 243–258. 10.1214/aoms/1177731088 Web of Science®Google Scholar 3 Wittes J,Brittain E. The role of internal pilot studies in increasing the efficiency of clinical trials. Statistics in Medicine 1990; 9: 65–72. 10.1002/sim.4780090113 CASPubMedWeb of Science®Google Scholar 4 Birkett MA, Day SJ. Internal pilot studies for estimating sample size. Statistics in Medicine 1994; 13: 2455–2463. 10.1002/sim.4780132309 CASPubMedWeb of Science®Google Scholar 5 Denne JS, Jennison C. Estimating the sample size for a t-test using an internal pilot. Statistics in Medicine 1999; 18: 1575–1585. 10.1002/(SICI)1097-0258(19990715)18:13 3.0.CO;2-Z CASPubMedWeb of Science®Google Scholar 6 Fisher L. Self-designing clinical trials. Statistics in Medicine 1998; 17: 1551–1562. 10.1002/(SICI)1097-0258(19980730)17:14 3.0.CO;2-E CASPubMedWeb of Science®Google Scholar 7 Bristol DR. Sample size determination using an interim analysis. Journal of Biopharmaceutical Statistics 1993; 3: 159–166. 10.1080/10543409308835057 CASPubMedGoogle Scholar 8 Herson J, Wittes J. The use of interim analysis for sample size adjustment. Drug Information Journal 1993; 27: 753–760. 10.1177/009286159302700317 Google Scholar 9 Shih WJ, Zhao PL. Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes. Statistics in Medicine 1997; 16: 1913–1923. 10.1002/(SICI)1097-0258(19970915)16:17 3.0.CO;2-Z CASPubMedWeb of Science®Google Scholar 10 Hennekens CH, Buring J. Methodologic considerations in the design and onduct of randomized trials: The U.S. physicians' health study. Controlled Clinical Trials 1998; 10: 142S–150S. 10.1016/0197-2456(89)90053-6 PubMedWeb of Science®Google Scholar 11 Bigger Jr, JT, Parides MK, Rolnitsk LM, Meier P, Levin B, Egan DA. Changes in sample size and length of follow-up to maintain power in the coronary artery bypass graft (CABG) patch trial. Controlled Clinical Trials 1998; 19: 1–14. 10.1016/S0197-2456(97)00124-4 PubMedWeb of Science®Google Scholar 12 Cook KD, Cook JR, Maurer BT, Kinosian B, Schumacher HR. Use of EM algorithm for reestimating sample size in a clinical trial for patients with osteoarthritis. Abstract No. 30, The International Biometric Society ENAR Spring Meeting, May 17–20, Richarmond, Virginia, 1996. Google Scholar 13 Shih WJ. Sample size reestimation in clinical trials. In Biopharmaceutical Sequential Statistical Applications, K Peace (ed). Marcel Dekker: New York, 1992; 285–301. Web of Science®Google Scholar 14 Shih WJ. Sample size reestimation for triple blind clinical trials. Drug Information Journal, 1993; 27: 761–764. 10.1177/009286159302700318 Google Scholar 15 Gould AL, Shih WJ. Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance. Communications in Statistics (A) – Theory and Methods 1992; 21(10): 2833–2853. 10.1080/03610929208830947 Web of Science®Google Scholar 16 Shih WJ, Gould AL. Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change. Statistics in Medicine 1995; 14: 2239–2248. 10.1002/sim.4780142007 CASPubMedWeb of Science®Google Scholar 17 Shih WJ, Long J. Blinded sample size re-estimation with unequal variances and center effects in clinical trials. Communications in Statistics–Theory and Methods 1998; 27: 395–408. 10.1080/03610929808832102 Web of Science®Google Scholar 18 Gould AL. Interim analyses for monitoring clinical trials that do not affect the type I error rate. Statistics in Medicine 1992; 11: 55–66. 10.1002/sim.4780110107 CASPubMedWeb of Science®Google Scholar 19 Gould AL, Shih WJ. Modifying the design of ongoing trials without unblinding. Statistics in Medicine 1998; 17: 89–100. 10.1002/(SICI)1097-0258(19980115)17:1 3.0.CO;2-D CASPubMedWeb of Science®Google Scholar 20 Herson J, Rodgers A. Spent/thrift design: The ultimate in flexibility. Joint Statistical Meetings, 4–8 August, Chicago, IL, 1996. Google Scholar 21 Shun Z, Yuan W, Brady W, Hsu H. Type I error in sample size re-estimations based on observed treatment difference. Statistics in Medicine 2000; 19: 497–513. Google Scholar 22 Dyck PJ, O'Brien PC. Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy. Diabetes Care 1989; 12: 649–652. 10.1002/mus.880110106 Google Scholar 23 Herson J. The affect of effect. Under the Curve, Newsletter of Applied Logic Associates, Inc. 1998; 4. Google Scholar 24 Temple R. Mid-course modifications in clinical trials. The Second Joint Meeting of Society for Clinical Trials and International Society for Clinical Biostatistics, Boston, MA, 6–10 July 1997. Google Scholar 25 Zucker DM, Wittes JT, Schabenberger O, Brittain E. Internal pilot studies II: Comparison of various procedures. Statistics in Medicine 1999; 18: 3493–3509. 10.1002/(SICI)1097-0258(19991230)18:24 3.0.CO;2-2 CASPubMedWeb of Science®Google Scholar Citing Literature Volume20, Issue428 February 2001Pages 515-518 ReferencesRelatedInformation
Referência(s)